Huashan Hospital
Clinical trials sponsored by Huashan Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a 1-Month pill course stop TB in schools? Results expected Sep 2026 (estimated)
- 33,000 hepatitis b patients enrolled in landmark Long-Term treatment study Results expected Nov 2026 (estimated)
- Can a 'Mini Tumor' in a dish predict your best cancer drug? Results expected Nov 2026 (estimated)
- New hope for aggressive brain cancer? early trial launches for recurrent glioblastoma Results expected Nov 2026 (estimated)
- Tumor 'Mini-Me' tested to match cancer drugs to patients Results expected Nov 2026 (estimated)
-
Brain pressure sensor may guide better recovery after aneurysm rupture
Disease control OngoingThis trial investigates whether using a device to continuously measure pressure inside the brain's fluid-filled spaces can improve outcomes for people who have had a bleeding stroke from a ruptured aneurysm. About 372 adults with moderate to severe bleeding will be randomly assig…
Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Multiple sclerosis CAR-T trial pulled before it even started
Disease control CancelledThis early-stage study aimed to test a single infusion of GC012F CAR-T cells in people with multiple sclerosis. The goal was to check safety and see if the treatment could control the disease. However, the trial was withdrawn before enrolling any participants, so no data was coll…
Early phase 1 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New hope for Drug-Resistant TB: a 6-Month pill regimen
Disease control OngoingThis phase 3 trial is testing a 6-month, all-oral combination of four drugs (bedaquiline, delamanid, linezolid, and levofloxacin or clofazimine) to treat rifampin-resistant tuberculosis in Chinese teenagers and adults aged 12 and older. The goal is to see if this shorter regimen …
Phase 3 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:02 UTC
-
New study tracks how DM1 affects chinese patients over time
Knowledge-focused By invitation onlyThis study follows 1000 Chinese patients with myotonic dystrophy type 1 (DM1) to understand how the disease affects multiple body systems and leads to disability. Researchers will collect health data and blood samples every 3 to 6 months for several years. The goal is to identify…
Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Can personalized nutrition slow kidney decline? new study investigates
Knowledge-focused By invitation onlyThis study follows 1,800 adults with reduced kidney function (not on dialysis) to see how nutrition and lifestyle affect their health. Researchers will track changes in kidney function, heart health, bone health, and thinking skills over time. The goal is to find better ways to m…
Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC